Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-09-05 to 2024-09-16
Current total value of award: $1120.32
Description: 8510872079!CLONAZEPAM TABLETS